The Brazilian doctor Jorge Moll, and his research team at D’or Institute of Research and Education is continuing to widen their research on moral cognitive neurosciences and furthering Dr. Jorge Moll’s previous research that confirmed emotions and morality will cause changes within the brain that is visible through fMRI imaging.
Identifying and visually recording, through fMRI, the effects our emotions and choices cause within our brain is Dr. Jorge Moll’s passion. His 2003 thesis, fMRI In Moral Judgement and Sensitivity began to conclusively link behavior with visible signs of emotion and behavior throughout different ranges within the brain. Dr. Moll’s conclusions solidified in 2005 when, with Jordan Grafman, fMRI imaging recorded the pleasure centers of the brain being activated by charitable giving, leading researchers to conclude that the human brain is happy with generosity and has provided much-needed neurological imaging. The continued expansion of Dr. Jorge Moll’s research has created breakthroughs in the neurological understanding of feelings and have led to projects at the D’or Institute designed to further expand the research of cognitive neurological imaging into areas of biofeedback, appetite and cravings and social development.
This research conducted by Dr. Jorge Moll will continue to immense value to the future of neurology and psychiatry. By establishing a complete map of the brain that identifies the specific and overlapping areas that respond to social interaction, choices and moral decisions, treatments will be developed to reduce the effect of traumatic brain injuries and effective therapies will be created for mental illnesses and degenerative neurological disorders.
Dr. Jorge Molls images identifying the changes of our brain makes during cognitive processes and emotional moments, along with the current research being done at the D’or Institute have created an insight into our behavioral repercussions on our brains and offer a needed catalyst for improved therapies for neurological diseases and advanced patient treatment options.